Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers

  • Lee, Jae-Mok (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Libermann, Towia A. (BIDMC Genomics Center, Harvard Medical School) ;
  • Cho, Je-Yoel (Department of Oral Biochemistry, Kyungpook National University School of Dentistry)
  • Published : 2010.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Bone tissues for clinical application can be improved by studies on osteoblast differentiation. Runx2 is known to be an important transcription factor for osteoblast differentiation. However, bone morphogenetic protein (BMP)-2 treatment to stimulate Runx2 is not sufficient to acquire enough bone formation in osteoblasts. Therefore, it is necessary to find other regulatory factors which can improve the transcriptional activity of Runx2. The erythroblast transformation-specific (ETS) transcription factor family is reported to be involved in various aspects of cellular proliferation and differentiation. Methods: We have noticed that the promoters of osteoblast differentiation markers such as alkaline phosphatase (Alp), osteopontin (Opn), and osteocalcin (Oc) contain Ets binding sequences which are also close to Runx2 binding elements. Luciferase assays were performed to measure the promoter activities of these osteoblast differentiation markers after the transfection of Runx2, myeloid Elf-1-like factor (MEF), and Runxs+MEF. Reverse-transcription polymerase chain reaction was also done to check the mRNA levels of Opn after Runx2 and MEF transfection into rat osteoblast (ROS) cells. Results: We have found that MEF, an Ets transcription factor, increased the transcriptional activities of Alp, Opn, and Oc. The addition of Runx2 resulted in the 2- to 6-fold increase of the activities. This means that these two transcription factors have a synergistic effect on the osteoblast differentiation markers. Furthermore, early introduction of these two Runx2 and MEF factors significantly elevated the expression of the Opn mRNA levels in ROS cells. We also showed that Runx2 and MEF proteins physically interact with each other. Conclusions: Runx2 interacts with MEF proteins and binds to the promoters of the osteoblast markers such as Opn nearby MEF to increase its transcriptional activity. Our results also imply that osteoblast differentiation and bone formation can be increased by activating MEF to elicit the synergistic effect of Runx2 and MEF.

Keywords

References

  1. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42. https://doi.org/10.1038/nature01658
  2. Blair HC, Zaidi M, Schlesinger PH. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 2002;364:329-41. https://doi.org/10.1042/BJ20020165
  3. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Mineral Metab 2000;18:344-9. https://doi.org/10.1007/s007740070007
  4. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002;2:389-406. https://doi.org/10.1016/S1534-5807(02)00157-0
  5. Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 2004;229:293-309. https://doi.org/10.1016/j.jtbi.2004.03.023
  6. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8. https://doi.org/10.1126/science.289.5484.1504
  7. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289:1501-4. https://doi.org/10.1126/science.289.5484.1501
  8. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-355. https://doi.org/10.1038/nature01660
  9. Olsen BR, Reginato AM, Wang W. Bone development. Ann Rev Cell Dev Biol 2000;16:191-220. https://doi.org/10.1146/annurev.cellbio.16.1.191
  10. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59. https://doi.org/10.1034/j.1601-0825.2002.01829.x
  11. Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev 2001;11:527-32. https://doi.org/10.1016/S0959-437X(00)00228-8
  12. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008;13:2001-21. https://doi.org/10.2741/2819
  13. Raouf A, Seth A. Ets transcription factors and targets in osteogenesis. Oncogene 2000;19:6455-63. https://doi.org/10.1038/sj.onc.1204037
  14. Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 1996;13:1721-9.
  15. Suico MA, Koyanagi T, Ise S, Lu Z, Hisatsune A, Seki Y, et al. Functional dissection of the ETS transcription factor MEF. Biochim Biophys Acta 2002;1577:113-20. https://doi.org/10.1016/S0167-4781(02)00370-6
  16. Hedvat CV, Yao J, Sokolic RA, Nimer SD. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 2004;279:6395-400. https://doi.org/10.1074/jbc.M307524200
  17. Lu Z, Kim KA, Suico MA, Shuto T, Li JD, Kai H. MEF upregulates human beta-defensin 2 expression in epithelial cells. FEBS Lett 2004;561:117-21. https://doi.org/10.1016/S0014-5793(04)00138-3
  18. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278:34387-94. https://doi.org/10.1074/jbc.M211386200
  19. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999;274:6972-8. https://doi.org/10.1074/jbc.274.11.6972
  20. Towler DA, Bennett CD, Rodan GA. Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 1994;8:614-24. https://doi.org/10.1210/me.8.5.614
  21. Towler DA, Rutledge SJ, Rodan GA. Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 1994;8:1484-93. https://doi.org/10.1210/me.8.11.1484
  22. Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003;31:342-50. https://doi.org/10.1016/S1079-9796(03)00162-1
  23. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64. https://doi.org/10.1016/S0092-8674(00)80258-5
  24. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998;17:1517-25. https://doi.org/10.1038/sj.onc.1202064
  25. Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 2006;281:18973-82. https://doi.org/10.1074/jbc.M511962200

Cited by

  1. Osteomimicry of Mammary Adenocarcinoma Cells In Vitro ; Increased Expression of Bone Matrix Proteins and Proliferation within a 3D Collagen Environment vol.7, pp.7, 2012, https://doi.org/10.1371/journal.pone.0041679
  2. Roles and regulations of the ETS transcription factor ELF4/MEF vol.9, pp.3, 2017, https://doi.org/10.1093/jmcb/mjw051
  3. Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis vol.8, pp.58, 2010, https://doi.org/10.18632/oncotarget.21000
  4. The microRNA-10a/ID3/RUNX2 axis modulates the development of Ossification of Posterior Longitudinal Ligament vol.8, pp.None, 2010, https://doi.org/10.1038/s41598-018-27514-x
  5. Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-018-37521-7
  6. BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway vol.10, pp.25, 2010, https://doi.org/10.7150/thno.47432
  7. The Positive Effect of TET2 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells vol.22, pp.1, 2010, https://doi.org/10.1089/cell.2019.0045